EXANE DERIVATIVES - PLX PHARMA INC ownership

PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 49 filers reported holding PLX PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of PLX PHARMA INC
ValueSharesWeighting
Q2 2022$15,974,000
-70.5%
6,575
-51.0%
0.01%
-40.0%
Q1 2022$54,161,00013,4070.02%
Other shareholders
PLX PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 62,673$346,0000.38%
Park West Asset Management LLC 1,473,218$8,132,0000.17%
Heritage Way Advisors, LLC 41,712$230,0000.11%
Cranbrook Wealth Management, LLC 7,500$41,0000.01%
683 Capital Management, LLC 30,000$166,0000.01%
Renaissance Technologies 139,083$768,0000.00%
WELLS FARGO & COMPANY/MN 460$2,0000.00%
NORTHERN TRUST CORP 10,043$55,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 15,326$85,0000.00%
View complete list of PLX PHARMA INC shareholders